Decreasing hepatitis C virus infection in Thailand in the past decade: Evidence from the 2014 national survey

PLoS ONE

Volumn 11, Issue 2, 2016, Pages

  Wasitthankasem, Rujipat ^a   Posuwan, Nawarat ^a   Vichaiwattana, Preeyaporn ^a   Theamboonlers, Apiradee ^a   Klinfueng, Sirapa ^a   Vuthitanachot, Viboonsak ^b   Thanetkongtong, Napha ^b   Saelao, Siriporn ^c   Foonoi, Monthana ^c   Fakthongyoo, Apinya ^c   Makaroon, Jamorn ^d   Srisingh, Klaita ^e   Asawarachun, Duangporn ^f   Owatanapanich, Somchai ^g   Wutthiratkowit, Norra ^h   Tohtubtiang, Kraisorn ⁱ   Yoocharoen, Pornsak ^j   Vongpunsawad, Sompong ^a   Poovorawan, Yong ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

^b Chumpare Hospital   (Thailand)

^c Uttaradit Hospital   (Thailand)

^d Laboratory Medicine   (Thailand)

^e NARESUAN UNIVERSITY   (Thailand)

^f Phra Nakhon Si Ayutthaya Hospital   (Thailand)

^g King Narai Hospital   (Thailand)

^h Narathiwat Ratchanakarin Hospital   (Thailand)

ⁱ Trang Hospital   (Thailand)

^j MINISTRY OF PUBLIC HEALTH   (Thailand)

more..

Author keywords

[No Author keywords available]

Indexed keywords

NONSTRUCTURAL PROTEIN 5B; VIRUS ANTIBODY; VIRUS RNA; HEPATITIS C ANTIBODY;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; BLOOD ANALYSIS; CHILD; CONTROLLED STUDY; FEMALE; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HEALTH CARE POLICY; HEALTH SURVEY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; POPULATION GROUP; PREVALENCE; RESOURCE ALLOCATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; THAILAND; AGED; BLOOD; GENETICS; HEPACIVIRUS; ISOLATION AND PURIFICATION; MIDDLE AGED; PRESCHOOL CHILD; SEROEPIDEMIOLOGY; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; INFANT; MALE; MIDDLE AGED; PHYLOGENY; PREVALENCE; RNA, VIRAL; SEROEPIDEMIOLOGIC STUDIES; THAILAND; YOUNG ADULT;

EID: 84960533083     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0149362     Document Type: Article

References (48)

1. Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCVseroprevalence. Hepatology 2013;57:1333-1342. PMID: 23172780 doi: 10.1002/hep. 26141
2. WHO (2014) Hepatitis C. Available: http://www.who.int/mediacentre/factsheets/fs164/en/.
3. Hajarizadeh B, Grebely J, Dore GJ. Epidemiology and natural history of HCV infection. Nat Rev Gastroenterol Hepatol 2013;10:553-562. PMID: 23817321 doi: 10.1038/nrgastro.2013.107
4. Tanaka Y, Nishida N, Sugiyama M, Kurosaki M, Matsuura K, Sakamoto N, et al. Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C. Nat Genet 2009;41:1105-1109. PMID: 19749757 doi: 10.1038/ng.449
5. Suppiah V, Moldovan M, Ahlenstiel G, Berg T, Weltman M, Abate ML, et al. IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy. Nat Genet 2009;41:1100-1104. PMID: 19749758 doi: 10.1038/ng.447
6. Fellay J, Thompson AJ, Ge D, Gumbs CE, Urban TJ, Shianna KV, et al. ITPA gene variants protect against anaemia in patients treated for chronic hepatitis C. Nature 2010;464:405-408. PMID: 20173735 doi: 10.1038/nature08825
7. Kohli A, Shaffer A, Sherman A, Kottilil S. Treatment of hepatitis C: a systematic review. JAMA 2014;312:631-640. PMID: 25117132 doi: 10.1001/jama.2014.7085
8. Chhatwal J, Kanwal F, Roberts MS, Dunn MA. Cost-effectiveness and budget impact of hepatitis C virus treatment with sofosbuvir and ledipasvir in the United States. Ann Intern Med 2015;162:397-406. PMID: 25775312 doi: 10.7326/M14-1336
9. Pfeil AM, Reich O, Guerra IM, Cure S, Negro F, Müllhaupt B, et al. Cost-effectiveness analysis of sofosbuvir compared to current standard treatment in Swiss patients with chronic hepatitis C. PLOS One 2015;10:e0126984. PMID: 25974722 doi: 10.1371/journal.pone.0126984
10. Cure S, Guerra I, Camma C, Craxi A, Carosi G. Cost-effectiveness of sofosbuvir plus ribavirin with or without pegylated interferon for the treatment of chronic hepatitis C in Italy. J Med Econ 2015;18:678-690. PMID: 25891129 doi: 10.3111/13696998.2015.1040024
11. Chimparlee N, Oota S, Phikulsod S, Tangkijvanich P, Poovorawan Y. Hepatitis Band hepatitis C virus in Thai blood donors. Southeast Asian JTrop Med Public Health 2011;42:609-615. PMID: 21706939
12. Suwanagool S, Tieangrim S, Ratanasuwan W, Mekanantagosol S, Luengrojanakul P, Kunasol P. Seroprevalence of anti-HCV among HIV-infected persons and general population. J Med Assoc Thai 1995;78:611-617. PMID: 8576673
13. Ratanasuwan W, Sonji A, Tiengrim S, Techasathit W, Suwanagool S. Serological survey of viral hepatitis A, B, and C at Thai Central Region and Bangkok: a population base study. Southeast Asian J Trop Med Public Health 2004;35:416-420. PMID: 15691148
14. Sunanchaikarn S, Theamboonlers A, Chongsrisawat V, Yoocharoen P, Tharmaphornpilas P, Warinathien P, et al. Seroepidemiology and genotypes of hepatitis C virus in Thailand. Asian Pac J Allergy Immunol 2007;25:175-182. PMID: 18035806.
15. Akkarathamrongsin S, Hacharoen P, Tangkijvanich P, Theamboonlers A, Tanaka Y, Mizokami M, et al. Molecular epidemiology and genetic history of hepatitis C virus subtype 3a infection in Thailand. Intervirology 2013;56:284-294. PMID: 23838334 doi: 10.1159/000351621
16. Tamura K, Stecher G, Peterson D, Filipski A, Kumar S. MEGA6: Molecular Evolutionary Genetics Analysis version 6.0. Mol Biol Evol 2013;30:2725-2729. PMID: 24132122 doi: 10.1093/molbev/mst197
17. Sistayanarain A, Kunthalert D, Vipsoongnern Y. A shift in the hepatitis C virus genotype dominance in blood donor samples from Thailand. Mol Biol Rep 2011;38:4287-4290. PMID: 21113670 doi: 10. 1007/s11033-010-0552-x
18. Zhang Z, Yao Y, Wu W, Feng R, Wu Z, Cun W, et al. Hepatitis C virus genotype diversity among intravenous drug users in Yunnan Province, Southwestern China. PLOS One 2013;8:e82598. PMID: 24358211 doi: 10.1371/journal.pone.0082598
19. Fu Y, Qin W, Cao H, Xu R, Tan Y, Lu T, et al. HCV 6a prevalence in Guangdong province had the origin from Vietnam and recent dissemination to other regions of China: phylogeographic analyses. PLOS One 2012;7:e28006. PMID: 22253686 doi: 10.1371/journal.pone.0028006
20. Ng KT, Lee YM, Al-Darraji HA, Xia X, Takebe Y, Chan KG, et al. Genome sequence of the hepatitis C virus subtype 6n isolated from Malaysia. Genome Announc 2013;1:e00168-12. doi: 10.1128/genomeA.00168-12 PMID: 23409272
21. Kanistanon D, Neelamek M, Dharakul T, Songsivilai S. Genotypic distribution of hepatitis C virus in different regions of Thailand. J Clin Microbiol 1997;35:1772-1776. PMID: 9196191
22. Kao HH, Chen KS, Lin CL, Chang JJ, Lee CH. Utilization of Signal-to-Cutoff Ratio of Hepatitis C Virus Antibody Assay in Predicting HCV Viremia among Hemodialysis Patients. Nephron 2015;130:127-133. PMID: 26065912 doi: 10.1159/000430988
23. Vidimliski PD, Nikolov I, Geshkovska NM, Dimovski A, Rostaing L, Sikole A. Review: Occult hepatitis C virus infection: still remains a controversy. J Med Virol 2014;86:1491-1498. PMID: 24895180 doi: 10. 1002/jmv. 23979
24. Baid-Agrawal S, Schindler R, Reinke P, Staedtler A, Rimpler S, Malik B, et al. Prevalence of occult hepatitis C infection in chronic hemodialysis and kidney transplant patients. J Hepatol 2014;60:928-933. PMID: 24447875 doi: 10.1016/j.jhep. 2014.01.012
25. Sawanpanyalert P, Boonmar S, Maeda T, Matsuura Y, Miyamura T. Risk factors for hepatitis C virus infection among blood donors in an HIV-epidemic area in Thailand. J Epidemiol Community Health 1996;50:174-177. PMID: 8762384
26. Luksamijarulkul P, Thammata N, Tiloklurs M. Seroprevalence of hepatitis B, hepatitis C and human immunodeficiency virus among blood donors, Phitsanulok Regional Blood Center, Thailand. Southeast Asian J Trop Med Public Health 2002;33:272-279. PMID: 12236425
27. Songsivilai S, Jinathongthai S, Wongsena W, Tiangpitayakorn C, Dharakul T. High prevalence of hepatitis C infection among blood donors in northeastern Thailand. Am J Trop Med Hyg 1997;57:66-69. PMID: 9242321
28. Thaikruea L, Thongsawat S, Maneekarn N, Netski D, Thomas DL, Nelson KE. Risk factors for hepatitis C virus infection among blood donors in northern Thailand. Transfusion 2004;44:1433-1440. PMID: 15383015
29. Ishida T, Takao S, Settheetham-Ishida W, Tiwawech D. Prevalence of hepatitis Band C virus infection in rural ethnic populations of Northern Thailand. J Clin Virol 2002;24:31-35. PMID: 11744426
30. Verachai V, Phutiprawan T, Theamboonlers A, Chinchai T, Tanprasert S, Haagmans BL, et al. Prevalence and genotypes of hepatitis C virus infection among drug addicts and blood donors in Thailand. Southeast Asian J Trop Med Public Health 2002;33:849-851. PMID: 12757237
31. Jittiwutikarn J, Thongsawat S, Suriyanon V, Maneekarn N, Celentano D, Razak MH, et al. Hepatitis C infection among drug users in northern Thailand. Am J Trop Med Hyg 2006;74:1111-1116. PMID: 16760529
32. Garcia Comas L, Ordobas Gavin M, Sanz Moreno JC, Ramos Blazquez B, Gutierrez Rodriguez A, Astray Mochales J, et al. Prevalence of hepatitis C antibodies in the population aged 16-80 years in the Community of Madrid 2008-2009. J Med Virol 2015;87:1697-1701. PMID: 25989026 doi: 10.1002/jmv. 24219
33. Hart-Malloy R, Carrascal A, Dirienzo AG, Flanigan C, McClamroch K, Smith L. Estimating HCV prevalence at the state level: a call to increase and strengthen current surveillance systems. Am J Public Health 2013;103:1402-1405. PMID: 23763407 doi: 10.2105/AJPH.2013.301231
34. Gower E, Estes C, Blach S, Razavi-Shearer K, Razavi H. Global epidemiology and genotype distribution of the hepatitis C virus infection. J Hepatol 2014;61:S45-S57. PMID: 25086286 doi: 10.1016/j. jhep. 2014.07.027
35. Phanuphak P, Locharernkul C, Panmuong W, Wilde H. A report of three cases of AIDS in Thailand. Asian Pac J Allergy Immunol 1985;3:195-199. PMID: 2866780
36. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989;244:359-362. PMID: 2523562
37. Houghton M. Discovery of the hepatitis C virus. LiverInt 2009;29:82-88. PMID: 19207970 doi: 10. 1111/j.1478-3231.2008.01925.x
38. Nguyen VT, McLaws ML, Dore GJ (2007) Prevalence and risk factors for hepatitis C infection in rural north Vietnam. Hepatol Int 1:387-393. doi: 10.1007/s12072-007-9008-3 PMID: 19669334
39. Do SH, Yamada H, Fujimoto M, Ohisa M, Matsuo J, Akita T, et al. High prevalences of hepatitis B and C virus infections among adults living in Binh Thuan province, Vietnam. Hepatol Res 2014. doi: 10. 1111/hepr.12350 PMID: 24799322
40. Lwin AA, Shinji T, Khin M, Win N, Obika M, Okada S, et al. Hepatitis C virus genotype distribution in Myanmar: Predominance of genotype 6 and existence of new genotype 6 subtype. Hepatol Res 2007;37:337-345. PMID: 17441806
41. Yamada H, Fujimoto M, Svay S, Lim O, Hok S, Goto N, et al. Seroprevalence, genotypicdistribution and potential risk factors of hepatitis B and C virus infections among adults in Siem Reap, Cambodia. Hepatol Res 2014. doi: 10.1111/hepr.12367 PMID: 24905888
42. Akkarathamrongsin S, Praianantathavorn K, Hacharoen N, Theamboonlers A, Tangkijvanich P, Poovorawan Y. Seroprevalence and Genotype of Hepatitis C Virus among Immigrant Workers from Cambodia and Myanmar in Thailand. Intervirology 2011;54:10-16. PMID: 20689311 doi: 10.1159/000318884
43. Arguillas MO, Domingo EO, Tsuda F, Mayumi M, Suzuki H. Seroepidemiology of hepatitis C virus infection in the Philippines: a preliminary study and comparison with hepatitis B virus infection among blood donors, medical personnel, and patient groups in Davao, Philippines. Gastroenterol Jpn 1991;26:170-175. PMID: 1909261
44. Inoue Y, Sulaiman HA, Matsubayashi K, Julitasari, Iinuma K, Ansari A, et al. Genotypic analysis of hepatitis C virus in blood donors in Indonesia. Am J Trop Med Hyg 2000;62:92-98. PMID: 10761731
45. Caruana SR, Kelly HA, De Silva SL, Chea L, Nuon S, Saykao P, et al. Knowledge about hepatitis and previous exposure to hepatitis viruses in immigrants and refugees from the Mekong Region. Aust NZ J Public Health 2005;29:64-68. PMID: 15782875
46. Wang JE. A study on the epidemiology of hepatitis C infection among blood donors in Singapore. J Public Health Med 1995;17:387-391. PMID: 8639336
47. Haslina MN, Khairiah Y, Zainy DZ, Shafini MY, Rosnah B, Marini R. Seroprevalence of hepatitis C virus infection among blood donors in a teaching hospital in northeastern Malaysia. Southeast Asian J Trop Med Public Health 2012;43:668-673. PMID: 23077846
48. Gane EJ, Hyland RH, An D, Svarovskaia E, Pang PS, Brainard D, et al. Efficacy of Ledipasvirand Sofosbuvir, With or Without Ribavirin, for 12 Weeks in Patients With HCV Genotype 3 or 6 Infection. Gastroenterology 2015;149:1454-1461.e1. PMID: 26261007 doi: 10.1053/j.gastro.2015.07.063